CEO Jim Clemmer said the company has spent the last several years reshaping its portfolio and operating model, moving away ...

Johnson & Johnson (NYSE:JNJ) today announced preliminary results from a Phase 1b study evaluating pasritamig (JNJ-78278343), a first-in-class bispecific T-cell engaging antibody, in combination with ...

King Faisal Specialist Hospital and Research Centre (KFSH) in Riyadh has successfully introduced a pioneering high-intensity focused ultrasound (HIFU) treatment for prostate cancer for the first time ...

Vir stock catapulted Tuesday after the small biotech company smashed fourth-quarter sales views and signed a deal with Astellas Pharma.

Astellas and Vir Biotechnology to co-develop and co-commercialize VIR-5500 through a sharing of expenses and revenues -- Astellas to lead commercialization of VIR-5500 in the U.S. with Vir ...

(WISH) — The American Cancer Society reports that about one in eight men will be diagnosed with prostate cancer in their lifetime. The average age of men who get diagnosed is 67. Today, less than 1% ...

University of Iowa researchers said they have completed preliminary modeling for breast and prostate cancers, and are about a fourth of the way through a two-year project seeking to shed some light on ...

A new study from The University of Texas MD Anderson Cancer Center has found that treating prostate cancer early, before it spreads widely, can make a big difference. The research, published in The ...

Jerry McCormick near his San Diego home the day before prostate cancer surgery, Jan. 5, 2026. Photo by Ariana Drehsler for CalMatters This story is part of California Voices, a commentary forum aiming ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, researchers are using the same tactics to advance prostate cancer treatment. A recent ...